| NCT02669849 | Study to Assess the Efficacy and Safety of VX-210 in Subjects With Acute Traumatic Cervical Spinal Cord Injury | Vertex Pharmaceuticals Incorporated | | - Age 14 - 75 yrs
- Level C4-C7
AIS A, B- ≤ 72 hours
- Not have acute SCI from gunshot or penetrating/stab wound; non-traumatic SCI (e.g., transverse myelitis, acute disc herniation); brachial plexus injury; complete spinal cord transection; or multifocal SCI
| Ended | 70 | PHASE2, PHASE3 | Drug | Arm/hand function | - American Spinal Injury Association Impairment Scale (AIS): International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
- Capabilities of Upper Extremity Instrument (CUE- Q and CUE-T)
- Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)
- Spinal Cord Independence Measure (SCIM)
| 6 months | 01 July 2016 | 01 February 2016 | 40 | |
| NCT02676154 | Fesoterodine for Amelioration of Autonomic Dysreflexia (AD) Following Spinal Cord Injury (SCI) | University of British Columbia | | - Age 18 - 60 yrs
- Level C1-T6
AIS A, B, C, D- 1 years - 60 years
| Ended | 15 | PHASE2 | Drug | General health | | | 25 February 2016 | 08 February 2016 | 1 | |
| NCT02678494 | Brain-Train Home Based Pain Treatment | NHS Greater Glasgow and Clyde | | - Age 18 - 70 yrs
- Level -
AIS - All
| Ended | 10 | NA | | | | | 09 June 2016 | 09 February 2016 | 1 | |
| NCT02700178 | Biofeedback for Wheelchair Users | Mayo Clinic | | - Age 18 - 60 yrs
- Level C1-S5
AIS A, B, C, D- ≤ 60 years
| Ended | 10 | NA | | Arm/hand function | | | 01 April 2016 | 07 March 2016 | 1 | |
| NCT02701777 | Enhancing STDP After Spinal Cord Injury | VA Office of Research and Development | | - Age 18 - 85 yrs
- Level C1-L5
AIS A, B, C, D- ≥ 2 months
| Ended | 62 | NA | Technology | Arm/hand function | | | 01 March 2016 | 08 March 2016 | 1 | |
| NCT02703883 | Body Weight Support in Spinal Cord Injury | University of Chile | | - Age 18 - 70 yrs
- Level -
AIS - All
| Ended | 17 | NA | | | | | 01 July 2012 | 09 March 2016 | 1 | |
